Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123555713 | 12355571 | 3 | F | 20160215 | 20160815 | 20160511 | 20160824 | EXP | US-SA-2016SA089370 | AVENTIS | 89.00 | YR | E | M | Y | 87.00000 | KG | 20160824 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123555713 | 12355571 | 1 | PS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Oral | Y | N | UNK | 20839 | 75 | MG | QD | |||||
| 123555713 | 12355571 | 2 | SS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Oral | Y | N | UNK | 20839 | 75 | MG | QD | |||||
| 123555713 | 12355571 | 3 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Subcutaneous | Y | UNK | 0 | QOW | ||||||||
| 123555713 | 12355571 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 123555713 | 12355571 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 123555713 | 12355571 | 6 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | 0 | ||||||||||||
| 123555713 | 12355571 | 7 | C | DEXTROMETHORPHAN | DEXTROMETHORPHAN | 1 | Oral | 0 | 15 | MG | TID | ||||||||
| 123555713 | 12355571 | 8 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 0 | 12.5 | MG | QD | ||||||||
| 123555713 | 12355571 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | DOSE: 500 | 0 | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123555713 | 12355571 | 1 | Peripheral vascular disorder |
| 123555713 | 12355571 | 2 | Peripheral vascular disorder |
| 123555713 | 12355571 | 3 | Cardiovascular disorder |
| 123555713 | 12355571 | 4 | Hypertension |
| 123555713 | 12355571 | 5 | Hypercholesterolaemia |
| 123555713 | 12355571 | 6 | Upper respiratory tract infection |
| 123555713 | 12355571 | 7 | Cough |
| 123555713 | 12355571 | 8 | Hypertension |
| 123555713 | 12355571 | 9 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123555713 | 12355571 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123555713 | 12355571 | Dizziness | |
| 123555713 | 12355571 | Transient ischaemic attack | |
| 123555713 | 12355571 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123555713 | 12355571 | 1 | 20131009 | 20160211 | 0 | |
| 123555713 | 12355571 | 2 | 20160215 | 0 | ||
| 123555713 | 12355571 | 3 | 20160107 | 20160204 | 0 | |
| 123555713 | 12355571 | 4 | 20141017 | 0 | ||
| 123555713 | 12355571 | 5 | 20131009 | 0 | ||
| 123555713 | 12355571 | 6 | 20151009 | 0 | ||
| 123555713 | 12355571 | 7 | 20140106 | 0 | ||
| 123555713 | 12355571 | 8 | 20141017 | 0 | ||
| 123555713 | 12355571 | 9 | 20151009 | 0 |